Rapid Micro Biosystems Inc (RPID) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) has a cash flow conversion efficiency ratio of -0.071x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.37 Million) by net assets ($33.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Rapid Micro Biosystems Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Rapid Micro Biosystems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Rapid Micro Biosystems Inc for a breakdown of total debt and financial obligations.
Rapid Micro Biosystems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rapid Micro Biosystems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Prime Securities Limited
NSE:PRIMESECU
|
-0.056x |
|
Piscines Desjoyaux SA
PA:ALPDX
|
0.136x |
|
Scope Fluidics SA
WAR:SCP
|
-0.102x |
|
Tethys Petroleum Ltd
V:TPL
|
0.069x |
|
09women Co. Ltd.
KQ:366030
|
0.036x |
|
SDI Ltd
AU:SDI
|
0.112x |
|
Synchronoss Technologies Inc
NASDAQ:SNCR
|
0.711x |
|
CHINA NEW CITY COMM.
F:C7B
|
N/A |
Annual Cash Flow Conversion Efficiency for Rapid Micro Biosystems Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Rapid Micro Biosystems Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see RPID market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $33.21 Million | $-31.06 Million | -0.935x | -59.64% |
| 2024-12-31 | $75.35 Million | $-44.15 Million | -0.586x | -53.36% |
| 2023-12-31 | $117.99 Million | $-45.08 Million | -0.382x | -7.14% |
| 2022-12-31 | $164.17 Million | $-58.55 Million | -0.357x | -43.38% |
| 2021-12-31 | $220.98 Million | $-54.96 Million | -0.249x | +80.08% |
| 2020-12-31 | $24.82 Million | $-31.00 Million | -1.249x | -104.28% |
| 2019-12-31 | $-725.00K | $-21.15 Million | 29.168x | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more